This proposal is for continuation of research into the natural history, treatment and epidemiology of the statistical conduct, design, collation, and publication of childhood cancer. It will continue to emphasize multimodal aspects of the Children's Cancer Study Group which has realized such excellent results in the past in Wilms' tumors and rhabdomyosarcoma and has now helped in defining acute childhood lymphocytic leukemia as more than one disease entity which requires different treatments for different groups. Also, treatment has been improved in osteogenic sarcoma and Ewing's sarcoma and, though advances are more meager, there have also been statistical improvements in survival of neuroblastoma patients. Childhood nonlymphocytic leukemia patients have also shown improved survival and the Children's Cancer Study Group has now combined in a Groupwide study to compare bone marrow transplantation in first remission to more standard conventional chemotherapy in a controlled fashion. During the period from November, 1976 to December, 1979, 389 children with childhood cancer were seen at this institution; 182 with leukemia, 148 who were treated on study, 44 who were not on study, and 207 children with solid tumors. We have been a member of the Children's Cancer Study Group since 1959 and strong permanent referral patterns have been established. It is therefore anticipated that the patient load will continue to be stabilized and slightly increased over the next several years. A close working relationship with the adult leukemia center under Dr. E. Donnall Thomas at the Fred Hutchinson Cancer Research Center continues. This includes the exchange of professional personnel on the Fellowship level. Forty-three bone marrow transplantations on children with acute leukemia have been done at this institution from 11/1/76 to 12/1/79. Collaborative studies continue in immunology with the Fred Hutchinson Cancer Research Center, primarily through the efforts of Irwin D. Bernstein, M.D.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA010382-19
Application #
3555923
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1976-12-01
Project End
1988-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
19
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Geyer, J Russell; Sposto, Richard; Jennings, Mark et al. (2005) Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 23:7621-31
Neudorf, Steven; Sanders, Jean; Kobrinsky, Nathan et al. (2004) Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103:3655-61
Dudkin, Vadim Y; Miller, Justin S; Danishefsky, Samuel J (2004) Chemical synthesis of normal and transformed PSA glycopeptides. J Am Chem Soc 126:736-8
Sievers, Eric L; Lange, Beverly J; Alonzo, Todd A et al. (2003) Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia. Blood 101:3398-406
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Wells, Robert J; Reid, Joel M; Ames, Matthew M et al. (2002) Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 24:89-93
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7

Showing the most recent 10 out of 25 publications